EUR 386.0
(1.05%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | 29.98 Million | 32.04 Million | 36 Million | 37.51 Million | - | - |
Net Income | -579.59 Thousand | 355.39 Thousand | 660.94 Thousand | 825.25 Thousand | 745.56 Thousand | 632.68 Thousand |
Depreciation & Amortization | 14.99 Million | 16.02 Million | 18 Million | 18.75 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 579.59 Thousand | -355.39 Thousand | -660.94 Thousand | -825.25 Thousand | -745.56 Thousand | -632.68 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | 29.98 Million | 32.04 Million | 36 Million | 37.51 Million | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 29.98 Million | 32.04 Million | 36 Million | 37.51 Million | - | - |
Free Cash Flow | 29.98 Million | 32.04 Million | 36 Million | 37.51 Million | - | - |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 FY | 2017 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -579.59 Thousand | 355.39 Thousand | 660.94 Thousand | 825.25 Thousand | 745.56 Thousand | 632.68 Thousand |
Depreciation & Amortization | 14.99 Million | 16.02 Million | 18 Million | 18.75 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 579.59 Thousand | -355.39 Thousand | -660.94 Thousand | -825.25 Thousand | -745.56 Thousand | -632.68 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | 29.98 Million | 32.04 Million | 36 Million | 37.51 Million | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 29.98 Million | 32.04 Million | 36 Million | 37.51 Million | - | - |
Free Cash Flow | 29.98 Million | 32.04 Million | 36 Million | 37.51 Million | - | - |
002038
BTCY
NEOEN
DAVANGERE
000607
0874